BlackRock, Inc. (BLK) 13D/13G Filings for ADC Therapeutics SA (ADCT)

BlackRock, Inc. 13D and 13G filings for ADC Therapeutics SA:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-24
10:50 am
Sale		 2025-03-31 13G ADC Therapeutics SA
ADCT		 BlackRock Inc.
BLK		 4,913,153
5.000%		 -98,704decrease
(-1.97%)		 Filing
2025-02-03
6:10 pm
Purchase		 2024-12-31 13G ADC Therapeutics SA
ADCT		 BlackRock Inc.
BLK		 5,011,857
5.200%		 5,011,857increase
(New Position)		 Filing